Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $267.3 million.

  • Dexcom's Income from Continuing Operations rose 7620.3% to $267.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $836.3 million, marking a year-over-year increase of 4514.06%. This contributed to the annual value of $836.3 million for FY2025, which is 4514.06% up from last year.
  • Latest data reveals that Dexcom reported Income from Continuing Operations of $267.3 million as of Q4 2025, which was up 7620.3% from $283.8 million recorded in Q3 2025.
  • In the past 5 years, Dexcom's Income from Continuing Operations ranged from a high of $283.8 million in Q3 2025 and a low of -$5.3 million during Q4 2021
  • Over the past 5 years, Dexcom's median Income from Continuing Operations value was $110.6 million (recorded in 2023), while the average stood at $125.6 million.
  • Per our database at Business Quant, Dexcom's Income from Continuing Operations crashed by 10128.86% in 2021 and then soared by 183207.55% in 2022.
  • Quarter analysis of 5 years shows Dexcom's Income from Continuing Operations stood at -$5.3 million in 2021, then skyrocketed by 1832.08% to $91.8 million in 2022, then skyrocketed by 179.19% to $256.3 million in 2023, then tumbled by 40.81% to $151.7 million in 2024, then soared by 76.2% to $267.3 million in 2025.
  • Its last three reported values are $267.3 million in Q4 2025, $283.8 million for Q3 2025, and $179.8 million during Q2 2025.